NLTX Annual Current Assets
$99.13 M
-$44.85 M-31.15%
31 December 2022
Summary:
As of February 5, 2025, NLTX annual total current assets is $99.13 million, with the most recent change of -$44.85 million (-31.15%) on December 31, 2022. During the last 3 years, it has fallen by -$44.46 million (-30.96%).NLTX Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NLTX Quarterly Current Assets
$79.89 M
-$3.89 M-4.64%
30 September 2023
Summary:
As of February 5, 2025, NLTX quarterly total current assets is $79.89 million, with the most recent change of -$3.89 million (-4.64%) on September 30, 2023. Over the past year, it has dropped by -$28.96 million (-26.61%).NLTX Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NLTX Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -31.1% | -26.6% |
| 3 y3 years | -31.0% | -61.3% |
| 5 y5 years | -8.9% | -8.5% |
NLTX Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -49.0% | -61.3% |
Neoleukin Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $79.89 M(-4.6%) |
| June 2023 | - | $83.78 M(-2.2%) |
| Mar 2023 | - | $85.64 M(-13.6%) |
| Dec 2022 | $16.81 M(-12.8%) | $99.13 M(-8.9%) |
| Sept 2022 | - | $108.86 M(-8.1%) |
| June 2022 | - | $118.48 M(-9.1%) |
| Mar 2022 | - | $130.37 M(-9.5%) |
| Dec 2021 | $19.27 M(+20.5%) | $143.99 M(-8.0%) |
| Sept 2021 | - | $156.50 M(-6.6%) |
| June 2021 | - | $167.50 M(-7.6%) |
| Mar 2021 | - | $181.31 M(-6.8%) |
| Dec 2020 | $16.00 M(+366.8%) | $194.52 M(-5.8%) |
| Sept 2020 | - | $206.59 M(+57.7%) |
| June 2020 | - | $131.00 M(-6.2%) |
| Mar 2020 | - | $139.65 M(-2.7%) |
| Dec 2019 | $3.43 M(+656.5%) | $143.60 M(+112.5%) |
| Sept 2019 | - | $67.58 M(-7.7%) |
| June 2019 | - | $73.21 M(-2.2%) |
| Mar 2019 | - | $74.83 M(-3.0%) |
| Dec 2018 | $453.00 K | $77.17 M(-11.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | $87.29 M(-15.4%) |
| June 2018 | - | $103.24 M(+9.6%) |
| Mar 2018 | - | $94.22 M(-13.4%) |
| Dec 2017 | $1.50 M(-97.0%) | $108.83 M(-9.7%) |
| Sept 2017 | - | $120.57 M(-8.8%) |
| June 2017 | - | $132.19 M(+8.0%) |
| Mar 2017 | - | $122.44 M(+18.3%) |
| Dec 2016 | $50.90 M(+32.0%) | $103.48 M(-29.4%) |
| Sept 2016 | - | $146.61 M(+116.7%) |
| June 2016 | - | $67.65 M(-2.6%) |
| Mar 2016 | - | $69.49 M(-7.1%) |
| Dec 2015 | $38.55 M(+1717.4%) | $74.80 M(-36.6%) |
| Sept 2015 | - | $117.94 M(+296.3%) |
| June 2015 | - | $29.76 M(-15.0%) |
| Mar 2015 | - | $35.02 M(-10.9%) |
| Dec 2014 | $2.12 M(+501.2%) | $39.30 M(-2.6%) |
| Sept 2014 | - | $40.36 M(+11.1%) |
| June 2014 | - | $36.34 M(-35.4%) |
| Mar 2014 | - | $56.25 M(+267.7%) |
| Dec 2013 | $352.80 K(+27.0%) | $15.30 M |
| Dec 2012 | $277.90 K | - |
FAQ
- What is Neoleukin Therapeutics annual total current assets?
- What is the all time high annual current assets for Neoleukin Therapeutics?
- What is Neoleukin Therapeutics annual current assets year-on-year change?
- What is Neoleukin Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Neoleukin Therapeutics?
- What is Neoleukin Therapeutics quarterly current assets year-on-year change?
What is Neoleukin Therapeutics annual total current assets?
The current annual current assets of NLTX is $99.13 M
What is the all time high annual current assets for Neoleukin Therapeutics?
Neoleukin Therapeutics all-time high annual total current assets is $194.52 M
What is Neoleukin Therapeutics annual current assets year-on-year change?
Over the past year, NLTX annual total current assets has changed by -$44.85 M (-31.15%)
What is Neoleukin Therapeutics quarterly total current assets?
The current quarterly current assets of NLTX is $79.89 M
What is the all time high quarterly current assets for Neoleukin Therapeutics?
Neoleukin Therapeutics all-time high quarterly total current assets is $206.59 M
What is Neoleukin Therapeutics quarterly current assets year-on-year change?
Over the past year, NLTX quarterly total current assets has changed by -$28.96 M (-26.61%)